Atherotech announces Sponsorship Agreement with NLA

Aiming to boost advanced lipoprotein testing in lipid education and management, Atherotech Diagnostics Lab announces its Sponsorship Agreement with the National Lipid Association (NLA).

Atherotech's agreement for 2011 will provide the NLA with a sponsorship grant and support for educational programs, clinical conferences and also includes membership on the Industry Council.

As a member of the NLA Industry Council, Atherotech upholds the educational mission of the NLA and contributes to the NLA's goals of engaging its members in clinical lipidology. Atherotech will partner with the NLA to offer advanced lipid testing and inflammatory markers seminars at three upcoming meetings:

• Spring Clinical Lipid Update held March 11-13 at Hyatt Lost Pines in Austin, Texas
• NLA Annual Scientific Sessions held May 19-22 at the Sheraton Hotel and Towers in New York City
• Summer Clinical Update held August 26-28 at the Hilton Bonnet Creek in Orlando

"We are pleased to see that Atherotech has placed emphasis on the educational objectives of the NLA for its members," said Christopher Seymour, Executive Director of the National Lipid Association. "Atherotech clearly understands the value of enhancing the practice of clinical lipidology and the NLA greatly appreciates the support."

The NLA is a nonprofit, multidisciplinary medical society of more than 3,000 members dedicated to enhancing lipid management in clinical practice and reducing mortalities associated with atherosclerotic disease. The association provides a comprehensive educational approach for the community of practitioners in the field of clinical lipidology, which embraces lipid and lipoprotein metabolism, cardiometabolic disorders and obesity.

Atherotech Chief Medical Officer Michael E. Cobble, M.D, an NLA fellow, recently started a dialogue on the NLA community website, www.lipid.org, in order to answer member questions regarding advanced lipid testing strategies.